10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stentsScandinavian Cardiovascular Journal, 2014
- Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysisBMJ, 2013
- Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent PlacementThrombosis, 2012
- The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting StentsJACC: Cardiovascular Interventions, 2010
- Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical PracticeJAMA, 2008
- A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label IndicationsNew England Journal of Medicine, 2008
- A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery DiseaseJACC, 2007
- Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarctionEuropean Heart Journal, 2007
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007